SOUTH SAN FRANCISCO, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Anesiva, ( Nachrichten ) Inc. today announced that it has initiated a new Phase 2 study of Adlea(TM) (formerly 4975) for the relief of post-operative pain in patients undergoing total knee replacement surgery, also called total knee arthroplasty (TKA). Adlea is a long-acting, non-opiate analgesic drug designed to provide pain relief ...
From: www.finanznachrichten.de
Thursday, September 13, 2007
TM) for Pain Relief Following Knee Replacement Surgery
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t5NGUvadWcNTO4NiXVUALyqUSw7v3oCnJiKrw_5x17HiZhVv2nn0Aweh9DApUQOZD1Vl0NQMpYbEuXzuhdXlB3i9hykA=s0-d)
![PingOmatic AutoDiscovery [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vD8jhQpcEnPNC9qMY1NzxEP4PLawb_1jxlx6eWgwNQXC3ZBhh87gIsumjk438xl0xGQwDGA7IR0NJnvNKT9zb3h9Ac6kntvH7DCHnb8ZByk-xJU3Hfqh57dL0zpPfy=s0-d)
![Made with Palestinian Efforts [True]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vAUGe86jye9rDdC_DuavxnlswXxnQLhSG3JZfbN-iy3j7fo_TjR3kJ_jwFWzlRJ89WYmLA1meRa_fFkhVWGGRBd5hBovLCku6ESB_P8HLx685Z_Z0BQrXxWA=s0-d)
No comments:
Post a Comment